✦ LIBER ✦

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

✍ Scribed by Robert B. Couch; Patricia Winokur; Rebecca Brady; Robert Belshe; Wilbur H. Chen; Thomas R. Cate; Bryndis Sigurdardottir; Amy Hoeper; Irene L. Graham; Robert Edelman; Fenhua He; Diane Nino; Jose Capellan; Frederick L. Ruben

Book ID: 116960038
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 268 KB
Volume: 25
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2007.08.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A high dosage influenza vaccine induced

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

✍ Thomas R. Cate; Yolanda Rayford; Diane Niño; Patricia Winokur; Rebecca Brady; Ro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Immunogenicity, safety and consistency o

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine

✍ H. Keipp Talbot; Wendy Keitel; Thomas R. Cate; John Treanor; James Campbell; Reb 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Safety and immunogenicity of varying dos

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

✍ Lisa A. Jackson; Glenn Austin; Robert T. Chen; Richard Stout; Frank DeStefano; G 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Safety and immunogenicity of a quadrival

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults

✍ Greenberg, David P.; Robertson, Corwin A.; Noss, Michael J.; Blatter, Mark M.; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Safety and immunogenicity of MF59-adjuva

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

✍ S De Donato; D Granoff; M Minutello; G Lecchi; M Faccini; M Agnello; F Senatore; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Trivalent inactivated subunit influenza

Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity

✍ K.M. Giezeman; J. Nauta; I.A. de Bruijn; A.M. Palache 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 330 KB